IQInvest research note
25 AUG 2026 · 15:28 ET
VRTX
Vertex Pharmaceuticals Incorporated
$554.84
$7.25 (+1.32%)up 1.32%
25 August 2026 · delayed 15+ min
C
Cut-offs are the grader's own: 97+ for an A+, below 60 is an F.
Vertex Pharmaceuticals Incorporated earns a C on excellent profit margins (>20%) and strong ROE (>20%) but high debt-to-equity ratio (>2.0) and high P/B ratio (6.94). Good investment opportunity with solid fundamentals.
Adjusted for Moderate investors, Medium-term investors 8.0% suggested allocation Change these
IQ-VRTX-20260825engine v1 · 7-category weighted scorecard